An Expanded T2-FLAIR Mismatch Phenotype in IDH-Mutant Astrocytomas.

doi:10.1002/jmri.70404

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

An Expanded T2-FLAIR Mismatch Phenotype in IDH-Mutant Astrocytomas.

Journal of magnetic resonance imaging : JMRI - 1 Oct 2026

Hua Tiantian, Zhang Xiaokang, Li Junjie, Jin Ying, Qiu Jun, Liu Yuwei, Cheng Dan, Duan Yunyun, Liu Xing, Zhuo Zhizheng, Lin Song, Liu Yaou

Abstract excerpt

BACKGROUND: The T2-FLAIR mismatch (T2FM) sign is a highly specific imaging biomarker for isocitrate dehydrogenase (IDH)-mutant astrocytomas; however, its strict definition limits clinical applicability. PURPOSE: To determine whether an expanded T2FM (eT2FM) phenotype could improve identification of IDH-mutant astrocytomas and capture prognostic and biological information. STUDY TYPE: Retrospective. POPULATION:...

Read the complete abstract on PubMed

Topics

Humans
Isocitrate Dehydrogenase
Astrocytoma
Phenotype
Male
Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Brain Neoplasms

Magnetic Resonance Imaging

Adult

Female

Retrospective Studies

Middle Aged

Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 42321142
DOI: 10.1002/jmri.70404
PMCID: PMC13578547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Expanded T2-FLAIR Mismatch Phenotype in IDH-Mutant Astrocytomas.PMID 42321142Read ↗

T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: Variability and evolution.Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.Semantic proximity Read ↗

Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.Semantic proximity Read ↗

T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Comment on, "T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant".Semantic proximity Read ↗

The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.